EFFICACY AND TOLERABILITY OF AMLODIPINE/TELMISARTAN COMBINATION THERAPY IN HYPERTENSIVE PATIENTS WITH CARDIOVASCULAR RISK FACTORS

被引：0
|
作者：
不详
机构：
来源：
HEART | 2012年 / 98卷
关键词：
D O I：
10.1136/heartjnl-2012-302920j.59
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E180 / E180
页数：1
相关论文
共 50 条
  • [31] ANTIPROTEINURIC EFFECT OF TELMISARTAN/AMLODIPINE VERSUS LOSARTAN/AMLODIPINE COMBINATION IN MICROALBUMINURIC HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES
    Fogari, R.
    Preti, P.
    Lazzari, P.
    Mugellini, A.
    Zoppi, A.
    Corradi, L.
    Derosa, G.
    JOURNAL OF HYPERTENSION, 2009, 27 : S71 - S71
  • [32] COMPARISON OF THE EFFICACY AND SAFETY OF FIXED-DOSE S-AMLODIPINE/TELMISARTAN AND TELMISARTAN IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH TELMISARTAN
    Park, Chang
    Ahn, Tac
    Cho, Eun
    Kim, Won
    Kim, Hyung
    Rhu, Jac
    Kim, Chul
    Hyeon, Min
    Ha, Jong
    Pyeon, Wook
    Lee, Myeong
    JOURNAL OF HYPERTENSION, 2016, 34 : E293 - E294
  • [33] Fixed-dose valsartan plus hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors:: The vast study
    Ruilope, L
    Malacco, E
    Khder, Y
    Brönner, G
    Heintz, D
    JOURNAL OF HYPERTENSION, 2005, 23 : S117 - S117
  • [34] Fixed-dose valsartan plus hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors:: The vast study
    Ruilope, LM
    Malacco, E
    Khder, Y
    Bönner, G
    Heintz, D
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 72A - 73A
  • [35] Fixed-dose valsartan plus hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors: The vast study
    Ruilope, Luis M.
    Malacco, Ettore
    Brandao, Andraea
    Stolt, Pelle
    Kandra, Albert
    Heintz, Daniela
    Khder, Yasser
    JOURNAL OF HYPERTENSION, 2006, 24 : 142 - 142
  • [36] Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study
    Kim, Tae-Seok
    Rha, Seung-Woon
    Kim, Seok-Yeon
    Park, Dae-Gyun
    Sung, Ki-Chul
    Yoon, Myung-Ho
    Kim, Kye-Hoon
    Lee, Han-Cheol
    Kim, Woo-Sik
    Kim, Yong-Jin
    Ahn, Jeong-Cheon
    Rhee, Moo-Yong
    Cha, Dong-Hun
    Yoo, Byung-Su
    Park, Sang-Ho
    Yoo, Ki-Dong
    Jeon, Dong-Woon
    Yoon, Young-Won
    Cho, Sang-Kyoon
    Oh, Yong-Seog
    CLINICAL THERAPEUTICS, 2019, 41 (04) : 728 - 741
  • [37] Amlodipine/atorvastatin single pill for the management of hypertensive patients with additional cardiovascular risk factors
    Blank, Roy
    FUTURE CARDIOLOGY, 2006, 2 (02) : 145 - 159
  • [38] Results of Treatment With Telmisartan-Amlodipine in Hypertensive Patients
    Littlejohn, Thomas W., III
    Majul, Claudio R.
    Olvera, Rafael
    Seeber, Mary
    Kobe, Maureen
    Guthrie, Robert
    Oigman, Wille
    JOURNAL OF CLINICAL HYPERTENSION, 2009, 11 (04): : 207 - 213
  • [39] CARDIOVASCULAR OUTCOMES OF AMLODIPINE-BASED COMBINATION THERAPIES IN HIGH-RISK HYPERTENSIVE PATIENTS
    Lu, P. P.
    Meng, X.
    Hu, A. H.
    Wang, W.
    Ma, L. Y.
    Zhang, Y. Q.
    Zhang, X. Z.
    Ma, L. H.
    Liu, L. S.
    Zhou, X. L.
    CARDIOLOGY, 2018, 140 : 107 - 107
  • [40] Consistent efficacy of a fixed-dose valsartan plus HCTZ combination therapy vs amlodipine in hypertensive patients at additional cardiovascular risk with and without metabolic syndrome
    Malacco, E.
    Ruilope, L. M.
    Kandra, A.
    Brandao, A. A.
    Heintz, D.
    Khder, Y.
    JOURNAL OF HYPERTENSION, 2006, 24 : S165 - S165
12345